🐬
|
Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial
H. Janssens,
M. Janssen,
E. Lisdonk,
P. Riel,
C. Weel
|
8 |
2008 |
8 🐬
|
🐢
|
A diagnostic rule for acute gouty arthritis in primary care without joint fluid analysis.
H. Janssens,
J. Fransen,
E. H. van de Lisdonk,
P. V. van Riel,
C. van Weel,
M. Janssen
|
7 |
2010 |
7 🐢
|
🐜
|
Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study
13 auth.
D. Gerlag,
M. Safy,
K. I. Maijer,
M. W. Tang,
S. Tas,
M. Starmans-Kool,
A. V. van Tubergen,
M. Janssen,
M. D. de Hair,
M. Hansson,
...
N. de Vries,
A. Zwinderman,
P. Tak
|
7 |
2018 |
7 🐜
|
🐜
|
Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis
9 auth.
S. Wolde,
F. Breedveld,
B. Dijkmans,
J. Hermans,
J. Vandenbroucke,
M. V. D. Laar,
...
H. Markusse,
M. Janssen,
H. Brink
|
7 |
1996 |
7 🐜
|
🐜
|
Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial.
13 auth.
V. Klück,
T. Jansen,
M. Janssen,
A. Comarniceanu,
M. Efde,
Isak W. Tengesdal,
K. Schraa,
M. C. Cleophas,
C. Scribner,
D. Skouras,
...
C. Marchetti,
C. Dinarello,
L. Joosten
|
7 |
2020 |
7 🐜
|
🐜
|
Study for Updated Gout Classification Criteria: Identification of Features to Classify Gout
27 auth.
W. Taylor,
J. Fransen,
T. Jansen,
N. Dalbeth,
H. Schumacher,
Melanie Brown,
W. Louthrenoo,
J. Vázquez-Mellado,
M. Eliseev,
G. McCarthy,
L. Stamp,
F. Pérez-Ruiz,
F. Sivera,
H. Ea,
M. Gerritsen,
...
C. Scirè,
L. Cavagna,
Chingtsai Lin,
Yin‐Yi Chou,
A. Tausche,
A. B. Vargas‐Santos,
M. Janssen,
Jiunn-Horng Chen,
O. Slot,
M. Cimmino,
T. Uhlig,
T. Neogi
|
7 |
2015 |
7 🐜
|
🐜
|
Performance of Ultrasound in the Diagnosis of Gout in a Multicenter Study: Comparison With Monosodium Urate Monohydrate Crystal Analysis as the Gold Standard
29 auth.
A. Ogdie,
W. Taylor,
T. Neogi,
J. Fransen,
T. Jansen,
H. Schumacher,
W. Louthrenoo,
J. Vázquez-Mellado,
M. Eliseev,
G. McCarthy,
L. Stamp,
F. Pérez-Ruiz,
F. Sivera,
H. Ea,
M. Gerritsen,
...
G. Cagnotto,
L. Cavagna,
Chingtsai Lin,
Yin‐Yi Chou,
A. Tausche,
M. Lima Gomes Ochtrop,
M. Janssen,
Jiunn-Horng Chen,
O. Slot,
J. Lazovskis,
D. White,
M. Cimmino,
T. Uhlig,
N. Dalbeth
|
6 |
2017 |
6 🐜
|
🐬
|
Systemic corticosteroids for acute gout.
H. Janssens,
P. Lucassen,
F. V. D. Laar,
M. Janssen,
E. Lisdonk
|
6 |
2008 |
6 🐬
|
🐜
|
Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout
79 auth.
D. Bursill,
W. Taylor,
R. Terkeltaub,
A. Abhishek,
A. So,
A. B. Vargas‐Santos,
A. Gaffo,
A. Rosenthal,
A. Tausche,
A. Reginato,
B. Manger,
C. Scirè,
C. Pineda,
C. van Durme,
Chingtsai Lin,
...
C. Yin,
D. Albert,
Edyta Biernat‐Kałuża,
E. Roddy,
E. Pascual,
F. Becce,
F. Pérez-Ruiz,
F. Sivera,
F. Lioté,
G. Schett,
G. Nuki,
G. Filippou,
G. McCarthy,
Geraldo da Rocha Castelar Pinheiro,
H. Ea,
H. Tupinamba,
H. Yamanaka,
Hyon K. Choi,
J. Mackay,
James R ODell,
J. Vázquez Mellado,
J. Singh,
J. Fitzgerald,
L. Jacobsson,
L. Joosten,
L. Harrold,
L. Stamp,
M. Andrés,
M. Gutierrez,
M. Kuwabara,
M. Dehlin,
M. Janssen,
M. Doherty,
M. Hershfield,
M. Pillinger,
N. Edwards,
N. Schlesinger,
Nitin Kumar,
O. Slot,
S. Ottaviani,
P. Richette,
P. Macmullan,
P. Chapman,
P. Lipsky,
P. Robinson,
P. Khanna,
R. Gancheva,
R. Grainger,
Richard J. Johnson,
R. te Kampe,
R. Keenan,
S. Tedeschi,
Seoyoung C. Kim,
S. Choi,
T. Fields,
T. Bardin,
T. Uhlig,
T. Jansen,
T. Merriman,
T. Pascart,
T. Neogi,
V. Klück,
W. Louthrenoo,
N. Dalbeth
|
6 |
2019 |
6 🐜
|
🐜
|
Anakinra for the treatment of acute gout flares: a randomized, double-blind, placebo-controlled, active-comparator, non-inferiority trial.
10 auth.
C. Janssen,
M. O. Oude Voshaar,
H. Vonkeman,
T. Jansen,
M. Janssen,
M. Kok,
...
B. Radovits,
C. van Durme,
H. Baan,
M. A. van de Laar
|
6 |
2019 |
6 🐜
|